Furin‐mediated protein processing in infectious diseases and cancer

E Braun, D Sauter - Clinical & translational immunology, 2019 - Wiley Online Library
Proteolytic cleavage regulates numerous processes in health and disease. One key player
is the ubiquitously expressed serine protease furin, which cleaves a plethora of proteins at …

Interferons α and β in cancer: therapeutic opportunities from new insights

EC Borden - Nature Reviews Drug Discovery, 2019 - nature.com
Over the past decade, preclinical and clinical research have confirmed the essential role of
interferons for effective host immunological responses to malignant cells. Type I interferons …

[HTML][HTML] Interferon-induced guanylate-binding proteins: Guardians of host defense in health and disease

K Tretina, ES Park, A Maminska… - Journal of Experimental …, 2019 - rupress.org
Guanylate-binding proteins (GBPs) have recently emerged as central orchestrators of
immunity to infection, inflammation, and neoplastic diseases. Within numerous host cell …

What genes are differentially expressed in individuals with schizophrenia? A systematic review

AK Merikangas, M Shelly, A Knighton, N Kotler… - Molecular …, 2022 - nature.com
Schizophrenia is a severe, complex mental disorder characterized by a combination of
positive symptoms, negative symptoms, and impaired cognitive function. Schizophrenia is …

Whole-genome CRISPR screening identifies genetic manipulations to reduce immune rejection of stem cell-derived islets

E Sintov, I Nikolskiy, V Barrera, JHR Kenty, AS Atkin… - Stem cell reports, 2022 - cell.com
Human embryonic stem cells (hESCs) provide opportunities for cell replacement therapy of
insulin-dependent diabetes. Therapeutic quantities of human stem cell-derived islets (SC …

Type I interferons and dendritic cells in cancer immunotherapy

J Sprooten, P Agostinis, AD Garg - … Review of Cell and Molecular Biology, 2019 - Elsevier
Type I interferons (IFNs) facilitate cancer immunosurveillance, antitumor immunity and
antitumor efficacy of conventional cell death-inducing therapies (chemotherapy/radiotherapy …

GBP2 enhances glioblastoma invasion through Stat3/fibronectin pathway

S Yu, X Yu, L Sun, Y Zheng, L Chen, H Xu, J Jin, Q Lan… - Oncogene, 2020 - nature.com
Abstract Guanylate-binding protein 2 (GBP2) is an interferon-inducible large GTPase which
is crucial to the protective immunity against microorganisms. However, its biological function …

GBP3 promotes glioblastoma resistance to temozolomide by enhancing DNA damage repair

H Xu, J Jin, Y Chen, G Wu, H Zhu, Q Wang, J Wang… - Oncogene, 2022 - nature.com
Glioblastoma is the most common malignant brain cancer with dismal survival and
prognosis. Temozolomide (TMZ) is a first-line chemotherapeutic agent for glioblastoma, but …

[HTML][HTML] Subtyping of microsatellite stability colorectal cancer reveals guanylate binding protein 2 (GBP2) as a potential immunotherapeutic target

H Wang, Y Zhou, Y Zhang, S Fang… - … for immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Methods Unsupervised clustering was employed to classify immune class and non-immune
class in 1424 pMMR/MSS patients from six independent public datasets. This binary …

STC1 expression is associated with tumor growth and metastasis in breast cancer

ACM Chang, J Doherty, LI Huschtscha… - Clinical & experimental …, 2015 - Springer
Abstract Stanniocalcin-1 (STC1) is a secreted glycoprotein implicated in several pathologies
including retinal degeneration, cerebral ischemia, angiogenesis and inflammation. Aberrant …